Author Archives: admin


Stem Cell Clinic > Articles by: admin

3D Cell Culture Market by Business Growth, Development Factors, Applications, and Future Prospects 2020 2024 – Owned

By Stell Cell Research

The 3D cell culture market is witnessing a stable growth due to the factors, like huge investments by life science companies for R&D, development of automated large-scale cell culture systems, and rising need for organ transplantation. Lack of experienced and skilled professionals and budget restriction for small and medium-sized laboratories are factors constraining the growth of the 3D cell culture market. However, increasing focus on regenerative medicine and stem cell is acting as an opportunity in the future. The scaffold-based segment holds the largest market share in the global market. The use of hydrogels in the scaffold-based 3D cell culture is the key factor driving the scaffold-based segment, as they can be derived naturally from protein and ECM components (laminin, fibrin, hyaluronic acid, chitosan, etc.). These gels are also biocompatible.

Request a Sample Copy of the Report https://www.industryresearch.co/enquiry/request-sample/13999714

Scope of the Report:

This report analyzes and discusses the 3D cell culture market. The market has been segmented on the basis of technology, application, end user, and geography. Based on technology, the market has been segmented into extracellular matrices (scaffolds), bioreactors, gels, scaffold-free platforms, microchips, and other technologies. The market, based on application, has been divided into research, drug discovery, tissue engineering, clinical applications, stem cell biology, and other applications. Based on end user, the market has been segregated into research laboratories and institutes, biotechnology and pharmaceutical industries, hospitals and diagnostic centers, and others end users.

Top Manufacturers Are:

Key Market Trends:

Drug Discovery Segment is Expected to Exhibit the Fastest Growth Rate Over the Forecast Period

Conventionally, drug discovery has been carried out using animal models. However, with the explosion of drug molecules synthesized/discovered in the past two decades, there has been a growth in high-throughput screening. Consequently, drug discovery has become a process that was time-resource intensive. Additionally, animal testing is subject to ethical controversies. Consequently, the demand for alternative methods for drug testing and drug discovery processes has gained momentum.

A specific application of 3D cell culture in drug discovery is organ-on-chips. These systems are being extensively employed by cancer therapeutic manufacturers for improving the benefit-risk balance by targeting precisely a particular cell type, a defined biomechanism, or a precise receptor. The current up-trend in cancer therapeutics research is likely to further spur the application of 3D cell cultures in drug discovery. Over the forecast period, much novel cancer therapeutics are expected to receive market approval, which is likely to, in turn, drive the growth of the 3D cell culture market.

North America Captured the Largest Market Share and is Expected to Retain its Dominance

North America dominated the overall 3D cell culture market with the United States accounting as the major contributor to the market. The United States is focusing more on R&D and is currently spending a lot on it. This has resulted in increasing technological advancements in the country. Many American applicants feature among the main patent applicants for the 3D cell culture domain. American applicants tend to develop their technologies in the United States, as well as in Asia. In 2016, an international collaboration between the United States, the United Kingdom, and the Netherlands, cancer-research heavy-weights, aimed to grow 1,000 new cell lines for scientists to study. The project is also expected to use cutting-edge techniques to generate its models, which will include 3D cultures called organoids, and cells that have been reprogrammed to grow indefinitely in culture. ICTDCCS 2018, 20th International Conference on 3D Cell Culture Systems, was held in Boston (the United States) on April 23-24, 2018. These factors have augmented the US 3D cell culture market and it is expected to further increase in the future.

For More Information or Query or Customization Before Buying, Visit at https://www.industryresearch.co/enquiry/pre-order-enquiry/13999714

What 3D Cell Culture Market Research Offers:

And many more

Detailed TOC of 3D Cell Culture Market Segmented by Geography Growth, Trend, and Forecast:

1 INTRODUCTION 1.1 Study Deliverables 1.2 Study Assumptions 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS 4.1 Market Overview 4.2 Introduction to Market Drivers and Restraints 4.3 Market Drivers 4.3.1 Huge R&D Investment by Life Science Companies 4.3.2 Development of Automated Large-scale Cell Culture Systems 4.3.3 Rising Need for Organ Transplantation 4.3.4 Use of 3D Cell Culture Models as Alternative Tools for In Vivo Testing 4.3.5 Increasing Focus on Regenerative Medicine 4.4 Market Restraints 4.4.1 Lack of Experienced and Skilled Professionals 4.4.2 Budget Restriction for Small- and Medium-sized Laboratories 4.4.3 Lack of Consistency in 3D Cell Culture Products 4.4.4 Stringent Process Controls for Advanced Handling Capabilities 4.5 Industry Attractiveness- Porters Five Forces Analysis 4.5.1 Threat of New Entrants 4.5.2 Bargaining Power of Buyers/Consumers 4.5.3 Bargaining Power of Suppliers 4.5.4 Threat of Substitute Products 4.5.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION 5.1 By Technology 5.1.1 Extracellular Matrices (Scafffolds) 5.1.2 Bioreactors 5.1.3 Gels 5.1.4 Scaffold-free Platforms 5.1.5 Microchips 5.1.6 Other Technologies 5.2 By Application 5.2.1 Research 5.2.2 Drug Discovery 5.2.3 Tissue Engineering 5.2.4 Clinical Applications 5.2.5 Stem Cell Biology 5.2.6 Other Applications 5.3 By End User 5.3.1 Research Laboratories and Institutes 5.3.2 Biotechnology and Pharmaceutical Companies 5.3.3 Hospitals and Diagnostic Centers 5.3.4 Other End Users 5.4 Geography 5.4.1 North America 5.4.1.1 US 5.4.1.2 Canada 5.4.1.3 Mexico 5.4.2 Europe 5.4.2.1 UK 5.4.2.2 Germany 5.4.2.3 France 5.4.2.4 Italy 5.4.2.5 Spain 5.4.2.6 Rest of Europe 5.4.3 Asia-Pacific 5.4.3.1 China 5.4.3.2 Japan 5.4.3.3 India 5.4.3.4 Australia 5.4.3.5 South Korea 5.4.3.6 Rest of Asia-Pacific 5.4.4 Middle East & Africa 5.4.4.1 GCC 5.4.4.2 South Africa 5.4.4.3 Rest of Middle East & Africa 5.4.5 South America 5.4.5.1 Brazil 5.4.5.2 Argentina 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE 6.1 Company Profiles 6.1.1 3D Biotek LLC 6.1.2 Becton Dickinson and Company 6.1.3 Sigma Aldrich Corporation 6.1.4 Corning Incorporated 6.1.5 Thermo Fisher Scientific 6.1.6 Global Cell Solutions Inc. 6.1.7 Nanofiber Solutions Incorporation 6.1.8 Insphero AG 6.1.9 Lonza Group 6.1.10 Nano 3D Biosciences

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Purchase this Report (Price 4250 USD for single user license) https://www.industryresearch.co/purchase/13999714

Contact Us:

Name: Ajay More

Phone: US +14242530807/ UK +44 20 3239 8187

Email: [emailprotected]

Our Other Reports:

Modern Chandeliers Market Size, Share and CAGR Status 2020 Global Industry Data by Top Manufacturers, Business Boosting Strategies, Upcoming Trends, Emerging Growth Factors till 2026

Diisopropyl Adipate (DIPA) Market by Major Drivers 2020 Global Industry Insights by Global Players, Regional Segmentation, Growth, Applications, Value and Forecasts till 2026

Catalysts in Petroleum Refining and Petrochemical Market Share 2020: Global Industry Outlook by Growth Segments, Types, Applications, and End-User Analysis Industry Size, Forecast to 2026

Marine Internet Of Things (IoT) Market Size, Growth and Share Analysis by Leading Countries, Top Key Players, Regions, Forecast to 2020-2025 with COVID-19 Impact on Industry

Global Cold Pressed Juice Market 2020 Key Players Analysis with Regional Overview, Trends, Future Forecast, Competitive Breakdown, and Growth Projections till 2024

Equipment Rental Software Market Size Analysis 2020 Covers Future Scope of Key Players, Market Dynamics with Industry Share, COVID-19 Analysis and Forecast to 2024

Read the original here:
3D Cell Culture Market by Business Growth, Development Factors, Applications, and Future Prospects 2020 2024 - Owned

Global Stem Cell Therapy Market Research Analysis Including Growth Factors, Types And Application By Regions From 2020 To 2024 – Owned

By Stem Cell Medicine

Global Stem Cell Therapy Market Analysis to 2024 is a focused and comprehensive study of the Stem Cell Therapy industry with a focus on the global market trend. The information mentioned in the Global Stem Cell Therapy Market research report presents an overview of the latest trends observed in the global market. Besides, this report emphases on the latest events such as the technological developments and the product launches and their consequences on the Market. The research report delivers the global market revenue, parent market trends along with market attractiveness per market segment.

Get Free Pdf Sample Copy of this [emailprotected]:

https://www.globalmarketers.biz/report/medicine/global-stem-cell-therapy-market-2019-by-company,-regions,-type-and-application,-forecast-to-2024/130793#request_sample

Top Players of Stem Cell Therapy Market are:

Osiris Therapeutics NuVasive Chiesi Pharmaceuticals JCRPharmaceutical Pharmicell Medi-post Anterogen Molmed Takeda (TiGenix) Regional Stem Cell Therapy Market (regional production, demand and forecast by country):

The main goals of the research report elegant the overall market overview on Stem Cell Therapy market dynamics, historic volume and value, robust market methodology, Latest and future trends, Porters Five Forces Analysis, new technological development, cost structure, government policies and regulations, etc. Major companies, company overview, financial data, products and services, strategy analysis, key developments market competition, industry competition structure analysis, SWOT Analysis, etc.

Get Discount On This Comprehensive Report: https://www.globalmarketers.biz/discount_inquiry/discount/130793

KEY MARKET SEGMENTS

On the basis of types, the Stem Cell Therapy Market is primarily split into:

Autologous Allogeneic On the basis of applications, the Stem Cell Therapy Market covers:

Musculoskeletal Disorder Wounds & Injuries Cornea Cardiovascular Diseases Others

Which market factors are explained in the report?

Study Coverage:Covers significant companies, vital market segments, the scope of the products offered in the global Stem Cell Therapy market, the years considered and the study objectives.

Executive Summary:It contains a summary of the most important studies, the Stem Cell Therapy market growing rate, modest conditions, market drivers, trends and problems as well as macroscopic indicators.

Production by region:This Stem Cell Therapy report provides information on imports and exports, production, sales and key players in all examined regional markets.

Manufacturer Profile:Each Company defined in this section is screened based on a SWOT analysis, products, value, their capacity and other important factors.

Do Inquiry Before Purchase @ https://www.globalmarketers.biz/report/medicine/global-stem-cell-therapy-market-2019-by-company,-regions,-type-and-application,-forecast-to-2024/130793#inquiry_before_buying

Table of Contents

1 Stem Cell Therapy Market Overview

2 Global Stem Cell Therapy Competition by Manufacturers

3 Global Stem Cell Therapy Capacity, Revenue (Value) by Region)

4 Global Stem Cell Therapy Supply (Production), Export, Import by Region

5 Global Stem Cell Therapy Market Revenue (Value), Price Trend by Type

6 Global Stem Cell Therapy Market by Application

7 Global Stem Cell Therapy Company Profiles

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

9 Stem Cell Therapy Market Effect Factors Analysis

10 Global Stem Cell Therapy Market Forecast

11 Research Findings and Conclusion

12 Appendix

Get Full [emailprotected] https://www.globalmarketers.biz/report/medicine/global-stem-cell-therapy-market-2019-by-company,-regions,-type-and-application,-forecast-to-2024/130793#table_of_contents

Why Globalmarketers Reports:

Explore extensive library of market reports

Focus on Key Trends and Market Movements

24/7 Online and Offline Support

Most-detailed market segmentation

Latest Details, Current and future trends provides in this research report

Go here to see the original:
Global Stem Cell Therapy Market Research Analysis Including Growth Factors, Types And Application By Regions From 2020 To 2024 - Owned

Global Stem Cells Market 2020 Is Booming Across the Globe Explored in Latest Research by 2020-2024 – eRealty Express

By Embryonic Stem Cells

Global Stem Cells Market Analysis to 2024 is a focused and comprehensive study of the Stem Cells industry with a focus on the global market trend. The information mentioned in the Global Stem Cells Market research report presents an overview of the latest trends observed in the global market. Besides, this report emphases on the latest events such as the technological developments and the product launches and their consequences on the Market. The research report delivers the global market revenue, parent market trends along with market attractiveness per market segment.

Get Free Pdf Sample Copy of this [emailprotected]:

https://www.globalmarketers.biz/report/life-sciences/global-stem-cells-market-2019-by-manufacturers,-regions,-type-and-application,-forecast-to-2024/130519#request_sample

Top Players of Stem Cells Market are:

CCBC Vcanbio Boyalife Beikebiotech Regional Stem Cells Market (regional production, demand and forecast by country):

The main goals of the research report elegant the overall market overview on Stem Cells market dynamics, historic volume and value, robust market methodology, Latest and future trends, Porters Five Forces Analysis, new technological development, cost structure, government policies and regulations, etc. Major companies, company overview, financial data, products and services, strategy analysis, key developments market competition, industry competition structure analysis, SWOT Analysis, etc.

Get Discount On This Comprehensive Report: https://www.globalmarketers.biz/discount_inquiry/discount/130519

KEY MARKET SEGMENTS

On the basis of types, the Stem Cells Market is primarily split into:

Umbilical Cord Blood Stem Cell Embryonic Stem Cell Adult Stem Cell Other On the basis of applications, the Stem Cells Market covers:

Diseases Therapy Healthcare

Which market factors are explained in the report?

Study Coverage:Covers significant companies, vital market segments, the scope of the products offered in the global Stem Cells market, the years considered and the study objectives.

Executive Summary:It contains a summary of the most important studies, the Stem Cells market growing rate, modest conditions, market drivers, trends and problems as well as macroscopic indicators.

Production by region:This Stem Cells report provides information on imports and exports, production, sales and key players in all examined regional markets.

Manufacturer Profile:Each Company defined in this section is screened based on a SWOT analysis, products, value, their capacity and other important factors.

Do Inquiry Before Purchase @ https://www.globalmarketers.biz/report/life-sciences/global-stem-cells-market-2019-by-manufacturers,-regions,-type-and-application,-forecast-to-2024/130519#inquiry_before_buying

Table of Contents

1 Stem Cells Market Overview

2 Global Stem Cells Competition by Manufacturers

3 Global Stem Cells Capacity, Revenue (Value) by Region)

4 Global Stem Cells Supply (Production), Export, Import by Region

5 Global Stem Cells Market Revenue (Value), Price Trend by Type

6 Global Stem Cells Market by Application

7 Global Stem Cells Company Profiles

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

9 Stem Cells Market Effect Factors Analysis

10 Global Stem Cells Market Forecast

11 Research Findings and Conclusion

12 Appendix

Get Full [emailprotected] https://www.globalmarketers.biz/report/life-sciences/global-stem-cells-market-2019-by-manufacturers,-regions,-type-and-application,-forecast-to-2024/130519#table_of_contents

Why Globalmarketers Reports:

Explore extensive library of market reports

Focus on Key Trends and Market Movements

24/7 Online and Offline Support

Most-detailed market segmentation

Latest Details, Current and future trends provides in this research report

See the original post:
Global Stem Cells Market 2020 Is Booming Across the Globe Explored in Latest Research by 2020-2024 - eRealty Express

Embryos could be susceptible to COVID-19 from second week of pregnancy – Gulf News

By Stem Cell Doctors

Those planning a family should be even more cautious against infection Image Credit: Drew Hayes/ Unsplash

Human embryos could be susceptible to COVID-19 as early as the second week of pregnancy, if the mother gets sick, potentially affecting the chances of a successful pregnancy, according to a study.

Scientists at the UK's University of Cambridge and California Institute of Technology in the US found that genes thought to play a role in how the SARS-CoV-2 virus infects our cells have been found to be active in embryos as early as during the second week of pregnancy.

While initially recognised as causing respiratory disease, the SARS-CoV-2 virus, which causes COVID-19 disease, also affects many other organs, they said.

Advanced age and obesity are risk factors for complications but questions concerning the potential effects on foetal health and successful pregnancy for those infected with SARS-CoV-2 remain largely unanswered, according to the researchers.

In the journal Open Biology, the researchers described how they used technology to culture human embryos through the stage they normally implant in the body of the mother to look at the activity - or 'expression' - of key genes in the embryo. On the surface of the SARS-CoV-2 virus are large 'spike' proteins. Spike proteins bind to ACE2, a protein receptor found on the surface of cells in our body, the researchers explained. Both the spike protein and ACE2 are then cleaved, allowing genetic material from the virus to enter the host cell.

The virus manipulates the host cell's machinery to allow the virus to replicate and spread, they said.

The researchers found patterns of expression of the genes ACE2, which provide the genetic code for the SARS-CoV-2 receptor, and TMPRSS2, which provides the code for a molecule that cleaves both the viral spike protein and the ACE2 receptor, allowing infection to occur.

These genes were expressed during key stages of the embryo's development, and in parts of the embryo that go on to develop into tissues that interact with the maternal blood supply for nutrient exchange.

Gene expression requires that the DNA code is first copied into an RNA message, which then directs the synthesis of the encoded protein.

"Our work suggests that the human embryo could be susceptible to COVID-19 as early as the second week of pregnancy if the mother gets sick," said Professor Magdalena Zernicka-Goetz, who holds positions at both the University of Cambridge and Caltech.

"To know whether this really could happen, it now becomes very important to know whether the ACE2 and TMPRSS2 proteins are made and become correctly positioned at cell surfaces.

If these next steps are also taking place, it is possible that the virus could be transmitted from the mother and infect the embryo's cells," Zernicka-Goetz said.

Professor David Glover, also from Cambridge and Caltech, noted that genes encoding proteins that make cells susceptible to infection by the novel coronavirus become expressed very early on in the embryo's development.

"This is an important stage when the embryo attaches to the mother's womb and undertakes a major remodelling of all of its tissues and for the first time starts to grow, Glover said.

He added that COVID-19 could affect the ability of the embryo to properly implant into the womb or could have implications for future foetal health.

The team said that further research is required using stem cell models and in non-human primates to better understand the risk.

However, they said their findings emphasise the importance for women planning for a family to try to reduce their risk of infection.

Excerpt from:
Embryos could be susceptible to COVID-19 from second week of pregnancy - Gulf News

Seven principles to change the UK’s research culture – Times Higher Education (THE)

By Stell Cell Research

Recently a number of specific incidents, reports and surveys have shown that bullying and harassment are widespread in the research and innovation culture of the UK. This is unacceptable it damages individual lives, stifles outstanding research and hinders innovation. The need for change has been highlighted numerous times in the past 20 years, but insufficient progress has been made.

Bullying and harassment arise fromseveral factors across the research and innovation landscape, and individuals, institutions and funding organisations must all play a role in bringing consistent and significant cultural change. We believe that strong inclusive leadership is paramount. Senior management are critically important in setting the cultural tone of institutions and funding bodies and should lead by example demonstrating inclusive leadership practices and calling out bullying and harassment when they see it.

To support this, we suggest that institutions and funders should adopt a set of principles that hold individuals and their employers to account. This will help drive a cultural change in research benefiting individuals, making the UK a more attractive place to work, and improving the quality of research. These principles should include:

We believe that adopting these principles will empower individuals to speak up, protect alleged perpetrators against malicious accusations and enable institutions and funders to together develop processes that are fair and transparent. They provide a framework to deliver a cultural change for the research and innovation environment in the UK and start a constructive dialogue for action.

Excellent research is necessary, indeed essential, but no longer sufficient.

Signed in their personal capacity,

Jackie Hunter, former chief executive,Biotechnology and Biological Sciences Research Council Ruth McKernan, former chief executive, Innovate UK Sara Rankin,professor of leukocyte and stem cell biology, Imperial College London Ins Barroso, professor of diabetes, University of Exeter Sir Robert Lechler, senior vice-president and provost (health), Kings College London Sir Mike Brady, professor of oncological imaging, University of Oxford Geraint Rees, dean of the Faculty of Life Sciences, UCL Eleanor Riley, professor of immunology and infectious disease, University of Edinburgh Paul Stewart, executive dean of the Faculty of Medicine and Health, University of Leeds Sarah Teichmann, head of cellular genetics, Wellcome Sanger Institute

To add your signature to the letter, click here.

See the original post:
Seven principles to change the UK's research culture - Times Higher Education (THE)

Stem Cell Market Size, Share Analysis 2020 Business Strategies, Growth Opportunities, COVID 19 Outbreak, Emerging Technologies, Regional Trends and…

By Stem Cell Treatment

Stem Cell Market is analyzed with industry experts in mind to maximize return on investment by providing clear information needed for informed business decisions. This research will help both established and new entrants to identify and analyze market needs, market size, and competition. It explains the supply and demand situation, the competitive scenario, and the challenges for market growth, market opportunities, and the complication faced by prominent players.

Click here to get sample of the premium report: https://www.quincemarketinsights.com/request-sample-40210?utm_source= pf/hp

The reports authors have segmented the global market for Stem Cell by product, application, and region. Global market segments for Stem Cell will be analyzed based on market share, production, consumption, revenue, CAGR, market size, and more factors. The analysts have profiled leading players in the global market for Stem Cell, taking into account their recent developments, market share, sales, revenue, covered areas, product portfolios, and other aspects.

It has a wide-ranging analysis of the impact of these advancements on the markets future growth, wide-ranging analysis of these extensions on the markets future growth. The research report studies the market in a detailed manner by explaining the key facets of the market that are foreseeable to have a countable stimulus on its developing extrapolations over the forecast period.

Get ToC for the overview of the premium report https://www.quincemarketinsights.com/request-toc-40210?utm_source=pf/hp

Table of Contents:

Market Segmentation: By Source (Adult Stem Cell, Human Embryonic Cell, Pluripotent Stem Cell, and Others), By Application (Therapeutic and Drug Development and Discovery), By Treatment Type (Allogeneic, Autologous, and Syngeneic), By Stem Cell Banking (Service & Technology and Banking Type)

A detailed outline of the Global Stem Cell Market includes a comprehensive analysis of different verticals of businesses. North America, Europe, Asia Pacific, Middle East & Africa, and South America have been considered for the studies on the basis of several terminologies.

This is anticipated to drive the Global Stem Cell Market over the forecast period. This research report covers the market landscape and its progress prospects in the near future. After studying key companies, the report focuses on the new entrants contributing to the growth of the market. Most companies in the Global Stem Cell Market are currently adopting new technological trends in the market.

Finally, the researchers throw light on different ways to discover the strengths, weaknesses, opportunities, and threats affecting the growth of the Global Stem Cell Market. The feasibility of the new report is also measured in this research report.

The Key Players mentioned in our report are: Thermo Fisher Scientific, Qiagen NV, Sigma Aldrich, Becton, Dickinson and Company, and Stem Cell Technologies

Speak to analyst before buying this report https://www.quincemarketinsights.com/enquiry-before-buying-40210?utm_source=pf/hp

The report answers the following questions-

ABOUT US:

QMI has the most comprehensive collection of market research products and services available on the web. We deliver reports from virtually all major publications and refresh our list regularly to provide you with immediate online access to the worlds most extensive and up-to-date archive of professional insights into global markets, companies, goods, and patterns.

Contact:

Quince Market Insights

Office No- A109

Pune, Maharashtra 411028

Phone: APAC +91 706 672 4848 / US +1 208 405 2835 / UK +44 1444 39 0986

Email: [emailprotected]

Web: https://www.quincemarketinsights.com

Follow this link:
Stem Cell Market Size, Share Analysis 2020 Business Strategies, Growth Opportunities, COVID 19 Outbreak, Emerging Technologies, Regional Trends and...

Infection Control in Cancer Therapy market maintaining a strong outlook heres why – Levee Report

By Stem Cell Treatment

The latest research report published by Ample Market Research Infection Control in Cancer Therapy Market with 150 + pages of business strategy analysis taken up by key and emerging players in the industry and provides know-how on current market growth, environment, innovations, drivers, opportunities, market perspective, and status.

Understanding the segments helps in identifying the importance of different factors that aid market growth. Some of the Major Companies covered in this Research are Kimberly Clark Corporation, 3M Healthcare Company, Honeywell International, Inc., Getinge Group AB, Sterigenics International, Sakura Global Holding Company, Arizant Healthcare Inc., Nordion, Cisa S.P.A., Steris Corporation, Nordion, Inc., Ahlstrom Filtration LLC, Membrana GmbH, Synergy Health, Plc, Advanced Sterilization Products Services, Inc etc.

For a free sample + related report charts click [emailprotected]: https://www.amplemarketreports.com/sample-request/covid-19-outbreak-impact-on-global-infection-control-in-cancer-therapy-market-1862637.html

Browse in-depth TOC, market details, tables and figures on Infection Control in Cancer Therapy Market by Application (Radiation Therapy, Immunotherapy, Traditional Surgery, Stem Cell Transplant Therapy, Chemotherapy, Targeted Therapy, Photodynamic Therapy, Other, Market segment by Application, split into, Hospital, Pharmaceutical Companies, Medical device companies, Other), Product Type (Radiation Therapy, Immunotherapy, Traditional Surgery, Stem Cell Transplant Therapy, Chemotherapy, Targeted Therapy, Photodynamic Therapy, Other), Business Scope, Production, and Outlook, Estimate to 2025

At last, all parts of the Infection Control in Cancer Therapy Market are quantitatively also subjectively valued to think about the Global just as regional market equally. This market study presents basic data and true figures about the market giving a deep analysis of this market based on market trends, market drivers, constraints, and future prospects. The report supplies the worldwide monetary challenge with the help of Porters Five Forces Analysis and SWOT Analysis.

for more information or any query mail at [emailprotected]

The global impacts of the coronavirus disease 2019 (COVID-19) have significantly affected the Infrastructure in the overall market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future. Know more with the latest edition of Infection Control in Cancer Therapy Market Study; Early buyers will receive 20% customization free on report

Tap here if you have any question @: https://www.amplemarketreports.com/enquiry-before-buy/covid-19-outbreak-impact-on-global-infection-control-in-cancer-therapy-market-1862637.html

Customization of the report: The report can be tailored up to 3 companies or countries or 40 analyst hours according to your needs for added data.

The following points are highlighted on the basis of product- named segments and sub-market segments:

Infection Control in Cancer Therapy Market By Application/End-User (Value and Volume from 2019 to 2025) : Radiation Therapy, Immunotherapy, Traditional Surgery, Stem Cell Transplant Therapy, Chemotherapy, Targeted Therapy, Photodynamic Therapy, Other, Market segment by Application, split into, Hospital, Pharmaceutical Companies, Medical device companies, Other

Market By Type (Value and Volume from 2019 to 2025) : Radiation Therapy, Immunotherapy, Traditional Surgery, Stem Cell Transplant Therapy, Chemotherapy, Targeted Therapy, Photodynamic Therapy, Other

Infection Control in Cancer Therapy Market by Key Players: Kimberly Clark Corporation, 3M Healthcare Company, Honeywell International, Inc., Getinge Group AB, Sterigenics International, Sakura Global Holding Company, Arizant Healthcare Inc., Nordion, Cisa S.P.A., Steris Corporation, Nordion, Inc., Ahlstrom Filtration LLC, Membrana GmbH, Synergy Health, Plc, Advanced Sterilization Products Services, Inc

Geographically, this report is segmented into some key Regions, with the manufacture, depletion, revenue (million USD), and market share and growth rate of Infection Control in Cancer Therapy in these regions, from 2012 to 2022 (forecast), covering China, USA, Europe, Japan, Korea, India, Southeast Asia & South America and its Share (%) and CAGR for the forecasted period 2019 to 2025.

Key Development in the Market: This segment of the Infection Control in Cancer Therapy report fuses the major developments of the market that contains confirmations, composed endeavors, R&D, new thing dispatch, joint endeavors, and the relationship of driving members working in the market.

Informational Takeaways from the Market Study: The report Infection Control in Cancer Therapy matches the completely examined and evaluated data of the noticeable companies and their situation in the market considering the impact of Coronavirus. The measuring tools including SWOT analysis, Porters five powers analysis, and assumption return debt were utilized while separating the improvement of the key players performing in the market.

Purchase complete copy to get this report @: https://www.amplemarketreports.com/buy-report.html?report=1862637&format=1

Some important topic for stakeholders and business professionals to broaden their role in the Infection Control in Cancer Therapy Market :

Q 1. Which Region offers the most rewarding open doors for the market Ahead of 2020?

Q 2. What are probably the most encouraging, high-development scenarios for Infection Control in Cancer Therapy movement showcase by applications, types and regions?

Q 3. What segments grab most noteworthy attention in Infection Control in Cancer Therapy Market in 2019 and beyond?

Q 4. Who are the significant players confronting and developing in Infection Control in Cancer Therapy Market?

Q 5. What are the business threats and Impact of the COVID scenario Over the market Growth and Estimation?

For more information please read Content Table @: https://www.amplemarketreports.com/report/covid-19-outbreak-impact-on-global-infection-control-in-cancer-therapy-market-1862637.html

TOCs Main Pole:

Chapter 1 Infection Control in Cancer Therapy Market Business Overview

Chapter 2 Major Breakdown by Type [Radiation Therapy, Immunotherapy, Traditional Surgery, Stem Cell Transplant Therapy, Chemotherapy, Targeted Therapy, Photodynamic Therapy, Other]

Chapter 3 Major Application Wise Breakdown (Revenue & Volume)

Chapter 4 Manufacture Market Breakdown

Chapter 5 Sales & Estimates Market Study

Chapter 6 Key Manufacturers Production and Sales Market Comparison Breakdown

Chapter 8 Manufacturers, Deals and Closings Market Evaluation & Aggressiveness

Chapter 9 Key Companies Breakdown by Overall Market Size & Revenue by Type

Chapter 11 Business / Industry Chain (Value & Supply Chain Analysis)

Chapter 12 Conclusions & Appendix

Thank you for reading this article; you can also get a wise section or area report versions of individual chapters such as North America, Europe, or Asia.

About Author

Ample Market Research provides comprehensive market research services and solutions across various industry verticals and helps businesses perform exceptionally well. Our end goal is to provide quality market research and consulting services to customers and add maximum value to businesses worldwide. We desire to deliver reports that have the perfect concoction of useful data. Our mission is to capture every aspect of the market and offer businesses a document that makes solid grounds for crucial decision making.

Contact Address:

William James

Media & Marketing Manager

Address: 3680 Wilshire Blvd, Ste P04 1387 Los Angeles, CA 90010

Call: +1 (530) 868 6979

Email: [emailprotected]

https://www.amplemarketreports.com

Johnathan is Sr.Content Writer in Levee Report , He Expertise in Business Research

Read the original here:
Infection Control in Cancer Therapy market maintaining a strong outlook heres why - Levee Report

Dad with incurable cancer takes on 300 mile cycle challenge ahead of stem cell transplant – HeraldScotland

By Stem Cell Medicine

A FATHER-of-two with a rare and incurable cancer is to take on a cycle challenge ahead of a potentially life-changing stem cell transplant.

Andrew Slorance, 49, was first diagnosed with mantle cell lymphoma, a member of the non-Hodgkins lymphoma family in 2015 and had since gone on to have one transplant.

However, while he has been on a cocktail of drugs to help suppress the cancer, which is incurable, he needs to undergo a second transplant this time with a stem cell donor transplant.

His operation is now scheduled to go ahead later this year following a slight delay with the impact of coronavirus, but before then he will be saddling up for a 300-mile bike challenge in aid of Cancer Research UK next month.

I didnt think I would see my 50th birthday at one point following my diagnosis, but with developments in medicine and science I have benefited, said Mr Slorance. The cycle challenge is a way of giving back and helping to raise money for much-needed research which could save lives. It is also a chance for me to get out on the bike and keep me fit for my next operation.

Mr Slorance thought he was just recovering from a gastric flu in summer 2015, but after still feeling tired and sluggish he decided to get checked out.

Following tests I was told I had a rare and incurable cancer called mantle cell lymphoma. By December, I was undertaking a gruelling four-month programme of chemotherapy before a life-prolonging stem cell transplant in spring 2016. At the time of diagnosis, the average life expectancy for MCL wasnt great, but science and luck have been on my side.

Last year, Mr Slorance relapsed but has benefited from a new drug that is controlling his current cancer ahead of his big operation in January next year.

He added: It wont last forever, though, and I need to face another stem cell transplant, this time the much more riskier donor or allogeneic transplant. If it goes well it could prove curative. But if it fails, well then that is another story. The drugs wont control the cancer forever so it is about getting to the point to make sure you can get the benefit of the drugs before going for the transplant.

With this one being a donor transplant there could be more chance of rejection like with any organ transplant, but the long-term benefits could be much greater. They cant say absolutely at the stage that the transplant is curative.

While waiting for his transplant date, Mr Slorance had found focusing on the cycle challenge and it has been all the more enjoyable being able to get out as shielding restrictions eased. He has been working from home in his role for the Scottish Government and had to take precautions in the family home.

Mr Slorance added: With four of us in the house we had to look at ways of socially distancing.

I was sleeping and working in a bedroom and judged my meal times separately from the family. It was great to get out in the garden, but even then I would have my own little area while the others would have theirs.

It has certainly been hard in these times when no-one has been able to hug one another.

Mr Slorance has been building up his mileage daily and is attempting to cover the 300 miles this month in case he cant manage in the official month of September.

After three months of shielding I finally got out for exercise on June 18. Ive bought myself an electric bike. Not as a cheat but because it helps to neutralise the many hills around my Edinburgh home.

The pills I am taking have a side-effect that can cause joint pain. I have also been sleeping on a bed settee since March. Those things combined have left me with excruciatingly painful and uncomfortable knees and shoulders.

Without the extra help of an electric bike theres no way Id be able to manage the effort needed to tackle the climbs, but I do put a lot of effort in on the flat.

Already he has been building up from seven miles a day while returning to his commute and has already raised more than 3,000.

Mr Slorance said: I hope I can raise as much money as I can for Cancer Research UK. Charities have been affected by lockdown and raising money has not been easy. In the past I have raised money for Maggies Centres, but this seemed a good way to help.

I already owe my extended life to cancer research and new treatments, but the median survival rate for MCL has only increased to six to seven years, so I could really benefit from more scientific advances.

To donate go to fundraise.cancerresearchuk.org/page/andrews-cycle-300-fundraising-page-202

See the original post here:
Dad with incurable cancer takes on 300 mile cycle challenge ahead of stem cell transplant - HeraldScotland

Impact Analysis of COVID-19 on Pluripotent Stem Cell Market Outlook 2018-2025 by Emerging Trends, Technology, Leading Companies, And Future Forecast -…

By Stell Cell Research

Kenneth Research has recently published a report on the Global and Southeast Asia Pluripotent Stem Cell Industry which is anticipated to grow by a CAGR of X% during the forecast period 2013-2025.

Request To Fill The form for Sample Copy of This Report: https://www.kennethresearch.com/sample-request-10035866

The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).

The report emphasizes on several key market dynamics which includes the growth drivers, market opportunities, challenges and threats and focuses on the like Manufacturers, Product Type, Trends, Applications, Regional Analysis with insights on the size of the market by value and by volume, along with other key numeric which includes Y-o-Y growth rate, market attractiveness, and BPS analysis.

The Global and Southeast Asia Pluripotent Stem Cell Industry report utilizes various tools for the analysis of the dynamics which include SWOT analysis, PORTERs five forces analysis, PESTEL analysis, and others.

The Global and Southeast Asia Pluripotent Stem Cell Industry report also provides performance insights based on regions and is thereby further segmented by five major regions into North America, Europe, Asia Pacific, Latin America and the Middle East and Africa.

CLICK HERE FOR CUSTOM REPORT

These areas are further divided into regions which comprise of:

CLICK HERE FOR SAMPLE COPY OF REPORT

The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).

Table of Content:

Request To Fill The form for Sample Copy of This Report: https://www.kennethresearch.com/sample-request-10035866

About Kenneth Research:

Kenneth Research provides market research reports to different individuals, industries, associations, and organizations with the aim of helping them to take prominent decisions. Our research library comprises more than 10,000 research reports provided by more than 15 market research publishers across different industries. Our collection of market research solutions covers both the macro level as well as micro-level categories with relevant and suitable market research titles. As a global market research reselling firm, Kenneth Research provides significant analysis of various markets with pure business intelligence and consulting services on different industries across the globe. In addition to that, our internal research team always keeps a track of the international and domestic market for any economic changes impacting the products demand, growth, and opportunities for new and existing players.

Updated Research Report Available @Kenneth Research with impact analysis of COVID-19

Baby Cereal with DHA Market Contemporary Daybeds Market Contemporary Corner Sofa Market Contemporary Ceramic Vase Market Container Candle Market Construction Paper Market

Continue reading here:
Impact Analysis of COVID-19 on Pluripotent Stem Cell Market Outlook 2018-2025 by Emerging Trends, Technology, Leading Companies, And Future Forecast -...

Chromosomal Rearrangements Associated with Chemotherapeutic Drug Resistance | McDonnell Boehnen Hulbert & Berghoff LLP – JD Supra

By Stem Cell Medical Center

Chemotherapeutic drug resistance is one reason cancer remains an unsolved clinical problem despite the efforts ever since President Nixon declared his "War on Cancer" in 1971. Cancer cells, due in part to the genetic destabilization characteristic of the disease, are capable of expressing genes (normal or aberrant) that permit the cell to avoid the cytotoxic effect of such drugs with the patient providing the situs of selection for and growth of resistant cells. The phenomenon is certain tumor types can have more deleterious consequences than in others, and this is particularly true for glioblastomas (and their non-malignant counterparts, gliomas), cancer of the cells that protect neurons in brain. That organ, confined to the skull, cannot accommodate tumor growth without damaging the brain with which it is confined.

The chemotherapeutic drug of choice for treating glioblastomas is temezolomide (TMZ), an oral alkylating agent that had its chemotherapeutic effect by introducing alkyl groups onto nucleotide bases (preferably at the N-7 and O-6 positions of guanine and N-3 position of adenine) in tumor cell DNA preferentially (due to the greater amount of DNA synthesis occurring in these cells) and disrupting the process leading to cell death (the O-6 methylation having the greatest capacity to induce apoptosis or programmed cell death).O-6-methylguanosnine DNA methyltransferase (MGMT) is the cellular enzyme responsible for repairing alkylated bases in DNA and reduced expression of this gene (e.g., by hypermethylation of the MGMT promoter) is a biomarker for TMZ sensitivity in gliomas and glioblastomas. Recently, a multinational team of researchers* reported genetic rearrangements associated with TMZ resistance, in a paper entitled "MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas" published in Nature Communications. This paper shows a subset of gliomas with rearrangements in the MGMT gene that produce overexpression of the gene and resistance as a result. These authors screened 252 TMZ-treated recurrent gliomas by RNA sequencing and found eight different MGMT genetic fusions (designated BTRC-MGMT,CAPZB-MGMT,GLRX3-MGMT,NFYC-MGMT,RPH3A-MGMT, andSAR1A-MGMTin high-grade gliomas, HGG, andCTBP2-MGMTandFAM175B-MGMT in low-grade gliomas, LGG, in the paper) in seven patients (6 females) with recurrent disease, created by chromosomal rearrangement (see Figure 1c from paper; shown below). These individuals' tumors showed "significantly higher" expression of the rearranged MGMT gene product.

Upon further study, the authors report that five of the eight rearranged genes were located on Chromosome 10 in the vicinity of the MGMT gene itself. The breakpoint in the MGMT was uniformly found at the boundary of exon 2 of the MGMT gene, at a point 12 basepairs upstream of the ATG translation "start" codon. In three of the rearrangements, the breakpoint in the partner gene in the genetic fusion was found in the 5' untranslated region (UTR). All fusions were found to be in-frame (i.e., the reading frame of the MGMT transcript was not disrupted) and the functional regions of the MGMT protein (the methyltransferase domain and DNA-binding domain) were intact. A more fine-structure mapping experiment in the genetic rearrangement resulting in FAM175B-MGMTfound that the fusion was the consequence of a deletion of 4.8 Mb.

The effect of these rearrangements on MGMT expression was elucidated using CRIPSR-Cas9 to produce the BTRC-MGMT, NFYC-MGMT, SAR1A-MGMT, and CTBP2-MGMT rearrangements in cells of two glioblastoma cell lines, U251 and U87. When these cells and their untreated counterparts were challenged by growth in vitro with TMZ, only cells bearing the rearrangements (as confirmed by PCR analysis) were shown to be TMZ resistant. Unlike genetic rearrangements in other cancers that produce fusion proteins (such as the abl-bcr gene produced in chronic myelogenous leukemia bearing the diagnostic Philadelphia chromosome), because most of the rearrangements found involving the MGMT gene were located upstream of the initiation codon of the MGMT gene these authors reasoned that these rearrangements produce increased expression of MGMT leading to TMZ resistance because the cells were better able to repair the methylation injury and replicate functionally. This hypothesis was supported by real-time quantitative PCR analysis of MGMT transcripts in cells bearing the rearrangements, that showed a "striking" increase in expression of MGMT-encoding transcripts (an observation also found in tumors from patients whose gliomas or glioblastomas showed these rearrangements), and Western blot analysis confirmed higher expression levels of the MGMT protein. In two of the rearrangements (BTRC-MGMT and NFYC-MGMT), higher molecular weight fusion proteins were detected as predicted from the genetic data. These results were also replicated in patient tumor-derived stem cells for the BTRC-MGMTandSAR1A-MGMT rearrangements.

These results, and the researchers' conclusion that these rearrangements caused TMZ resistance by overexpression of MGMT, were confirmed by re-establishing TMZ sensitivity in these cells in the presence of O6-benzylguanine (O6-BG), an MGMT inhibitor. These results were further confirmed by detection of double-strand breaks in DNA in these cells in the presence of TMZ and O6-BG.

The relevance of these results to TMZ resistance in vivo was demonstrated using nude mouse xenograft models bearing tumors produced using BTRC-MGMT U251 cells and U251 cells without the rearrangement as control; these cells also contained a recombinant luciferase gene. Mice containing the rearrangement showed no significant prolongation of lifespan in the presence or absence of TMZ, indicating tumor cell resistance, whereas TMZ treatment of nave U251 cells showed improved survival.

While hypomethylation of the native MGMT promoter is the most frequently change associated with TMZ resistance, the results presented in this paper illustrate an alternative mechanism for glioblastomas and gliomas to acquire resistance to TMZ, the only current chemotherapeutic drugs for these maladies. Because these rearrangements were found in patients with recurrent tumors, these authors hypothesize that the rearrangements were selected or by TMZ treatment. A similar rearrangement has also been found in another cancer, medulloblastoma, after TMZ relapse. These authors also suggest that detection of these rearrangements can be used clinically to determine appropriate treatment modalities, particularly for recurrent disease.

* Seve Ballesteros Foundation Brain Tumor Group, Molecular Oncology Programme, Spanish National Cancer Research Center; Division of Life Science, Department of Chemical and Biological Engineering, Center of Systems Biology and Human Health and State Key Laboratory of Molecular Neuroscience, The Hong Kong University of Science and Technology; Beijing Neurosurgical Institute, Capital Medical University; Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine; Department of Systems Biology, Columbia University; The Jackson Laboratory for Genomic Medicine; and Molecular Cytogenetics Group, Human Cancer Genetics Program, Spanish National Cancer Research Center, CNIO, 28029, Madrid, Spain

See the rest here:
Chromosomal Rearrangements Associated with Chemotherapeutic Drug Resistance | McDonnell Boehnen Hulbert & Berghoff LLP - JD Supra

→←